Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Bacterial Agents | 5 | 2024 | 207 | 0.860 |
Why?
|
| Pseudomonas Infections | 2 | 2011 | 17 | 0.660 |
Why?
|
| Drug Resistance, Microbial | 1 | 2020 | 29 | 0.620 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 14 | 0.610 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2019 | 5 | 0.610 |
Why?
|
| Lung Diseases | 1 | 2019 | 13 | 0.600 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 25 | 0.600 |
Why?
|
| Klebsiella Infections | 3 | 2019 | 35 | 0.350 |
Why?
|
| Bacterial Proteins | 3 | 2019 | 48 | 0.350 |
Why?
|
| beta-Lactamases | 3 | 2019 | 42 | 0.350 |
Why?
|
| Klebsiella pneumoniae | 3 | 2019 | 38 | 0.350 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 17 | 0.330 |
Why?
|
| Cross Infection | 3 | 2019 | 129 | 0.300 |
Why?
|
| Humans | 14 | 2024 | 12240 | 0.300 |
Why?
|
| Genomics | 2 | 2024 | 26 | 0.270 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 74 | 0.250 |
Why?
|
| Intensive Care Units | 2 | 2024 | 119 | 0.240 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2024 | 2 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 39 | 0.210 |
Why?
|
| Enterobacteriaceae | 1 | 2024 | 16 | 0.210 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 40 | 0.210 |
Why?
|
| Clostridium Infections | 1 | 2023 | 19 | 0.200 |
Why?
|
| Feces | 2 | 2024 | 40 | 0.180 |
Why?
|
| Specimen Handling | 2 | 2023 | 21 | 0.170 |
Why?
|
| Phage Therapy | 1 | 2020 | 1 | 0.160 |
Why?
|
| Mycobacterium xenopi | 1 | 2019 | 2 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 51 | 0.140 |
Why?
|
| Bacteremia | 1 | 2019 | 53 | 0.140 |
Why?
|
| Adult | 3 | 2024 | 3557 | 0.140 |
Why?
|
| Female | 5 | 2024 | 6974 | 0.130 |
Why?
|
| Bacteria | 1 | 2017 | 34 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 8 | 0.100 |
Why?
|
| Baths | 1 | 2014 | 19 | 0.100 |
Why?
|
| Chlorhexidine | 1 | 2014 | 29 | 0.100 |
Why?
|
| Infection Control | 1 | 2014 | 76 | 0.100 |
Why?
|
| Skin | 1 | 2014 | 73 | 0.100 |
Why?
|
| Chicago | 3 | 2024 | 453 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 66 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 28 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2011 | 5 | 0.080 |
Why?
|
| Middle Aged | 4 | 2024 | 4043 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 76 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2011 | 26 | 0.080 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 38 | 0.080 |
Why?
|
| Male | 4 | 2024 | 6815 | 0.070 |
Why?
|
| Hospitals | 2 | 2019 | 68 | 0.070 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2024 | 9 | 0.050 |
Why?
|
| Epidemiological Monitoring | 1 | 2024 | 10 | 0.050 |
Why?
|
| Rectum | 1 | 2024 | 21 | 0.050 |
Why?
|
| Public Health | 1 | 2024 | 22 | 0.050 |
Why?
|
| Carrier State | 1 | 2024 | 29 | 0.050 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2024 | 20 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2024 | 3 | 0.050 |
Why?
|
| Monkeypox virus | 1 | 2024 | 2 | 0.050 |
Why?
|
| Biological Assay | 1 | 2024 | 3 | 0.050 |
Why?
|
| Culture Media | 1 | 2024 | 8 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 62 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2024 | 77 | 0.050 |
Why?
|
| Aged | 2 | 2024 | 4000 | 0.050 |
Why?
|
| Respiratory System | 1 | 2023 | 5 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2023 | 5 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 23 | 0.050 |
Why?
|
| United States | 1 | 2023 | 989 | 0.040 |
Why?
|
| Carbapenems | 1 | 2019 | 11 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 78 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 161 | 0.040 |
Why?
|
| Temperature | 1 | 2017 | 33 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 651 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 22 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 33 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 20 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 125 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 695 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hospital Administration | 1 | 2014 | 13 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 39 | 0.030 |
Why?
|
| Focus Groups | 1 | 2014 | 50 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 56 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 158 | 0.020 |
Why?
|